止盈止损空仓守住的个人主页 - 老虎社区

止盈止损空仓守住

止盈止损空仓守住

伟大的投资家

IP属地：广东

45关注

4粉丝

2主题

0勋章

止盈止损空仓守住

2024-06-27

什么情况，业绩好还下跌，业绩不好也下跌，全贫一张嘴，什么指引，扯淡

抱歉，原内容已删除

止盈止损空仓守住

2024-02-22

$Roku Inc(ROKU)$ 天天跌，垃圾股

止盈止损空仓守住

2024-02-20

这篇文章不错，转发给大家看看

抱歉，原内容已删除

止盈止损空仓守住

2024-02-15

垃圾吧，不罚他

抱歉，原内容已删除

止盈止损空仓守住

2023-12-07

万能的社区，有人知道现在公司股票英文咨询用啥翻译软件

止盈止损空仓守住

2023-09-25

不错

@33_Tiger:做时间的朋友 - 写给每个美股新朋友

止盈止损空仓守住

2023-01-23

看了一下前面交易记录，为啥kala买时1160股，卖时候总共只有46股（全部清仓kala），太坑了吧？谁帮我解答一下

止盈止损空仓守住

2022-06-07

$奥罗拉大麻公司(ACB)$下单为啥产生借款，啥意思

止盈止损空仓守住

2022-03-13

会爆发吗？

辉瑞Paxlovid药片下周获准仿制，最快将于12月前供应

止盈止损空仓守住

2022-02-11

$辉瑞(PFE)$每次都是盘前跌

止盈止损空仓守住

2022-02-08

预估，有用吗？按实际出发呀，瞎搞

抱歉，原内容已删除

止盈止损空仓守住

2022-01-26

$微软(MSFT)$搞鸡儿，财报利好还跌得厉害

止盈止损空仓守住

2022-01-22

利好，为啥跌跌不休

抱歉，原内容已删除

止盈止损空仓守住

2018-12-06

$惠普企业(HPE)$啥情况，难道和华为有关

止盈止损空仓守住

2018-11-02

$红帽(RHT)$天天双杀

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3463959459277747","uuid":"3463959459277747","gmtCreate":1500892384431,"gmtModify":1741704483920,"name":"止盈止损空仓守住","pinyin":"zyzskcszzhiyingzhisunkongcangshouzhu","introduction":"","introductionEn":"","signature":"伟大的投资家","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":45,"tweetSize":15,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.02%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.03","exceedPercentage":"93.73%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":321189833932888,"gmtCreate":1719445731405,"gmtModify":1719449461483,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"什么情况，业绩好还下跌，业绩不好也下跌，全贫一张嘴，什么指引，扯淡","listText":"什么情况，业绩好还下跌，业绩不好也下跌，全贫一张嘴，什么指引，扯淡","text":"什么情况，业绩好还下跌，业绩不好也下跌，全贫一张嘴，什么指引，扯淡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321189833932888","repostId":"2446441923","repostType":2,"isVote":1,"tweetType":1,"viewCount":2218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":276504536363232,"gmtCreate":1708534375415,"gmtModify":1708534455300,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$ &nbsp;</a>天天跌，垃圾股","listText":"<a href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$ &nbsp;</a>天天跌，垃圾股","text":"$Roku Inc(ROKU)$ 天天跌，垃圾股","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/276504536363232","isVote":1,"tweetType":1,"viewCount":3837,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":275919158886408,"gmtCreate":1708402125035,"gmtModify":1708402126497,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/275919158886408","repostId":"1142974079","repostType":4,"isVote":1,"tweetType":1,"viewCount":2495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":274329617059880,"gmtCreate":1708012769262,"gmtModify":1708013448631,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"垃圾吧，不罚他","listText":"垃圾吧，不罚他","text":"垃圾吧，不罚他","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/274329617059880","repostId":"2411599588","repostType":2,"isVote":1,"tweetType":1,"viewCount":2491,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":249531986985192,"gmtCreate":1701960978550,"gmtModify":1701960981372,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"万能的社区，有人知道现在公司股票英文咨询用啥翻译软件","listText":"万能的社区，有人知道现在公司股票英文咨询用啥翻译软件","text":"万能的社区，有人知道现在公司股票英文咨询用啥翻译软件","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/249531986985192","isVote":1,"tweetType":1,"viewCount":3107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":223707017080896,"gmtCreate":1695653128227,"gmtModify":1695653129618,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"不错","listText":"不错","text":"不错","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/223707017080896","repostId":"45492","repostType":1,"repost":{"id":45492,"gmtCreate":1487756403694,"gmtModify":1704875193978,"author":{"id":"740450932848","authorId":"740450932848","name":"33_Tiger","avatar":"https://static.tigerbbs.com/aa2c2a58a713dadbb19ede7c4c37d61d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"740450932848","authorIdStr":"740450932848"},"themes":[],"title":"做时间的朋友 - 写给每个美股新朋友","htmlText":"最近社区有个话题#为啥你亏钱#看的朋友很多，反思过去才能展望未来。 这篇标题借罗振宇老师的《时间的朋友》，我觉得投资是真正的要跟时间做朋友，这条路上的风景很美，有刺激、有平淡、有孤独、有浮躁， 但！首先你要活得够长。 进入2017年，我炒股也小十年了，美股第六年。运气很好，经历过闭着眼睛都赚钱的年份。但也亲眼看着$Facebook(FB)$从38刀上市破发、到腰斩再从18刀一路走到现在；见识过昔日明星股GTAT一夜暴跌90%+；全程跟踪了奇虎等中概股从上市到退市。 今天想跟初入美股的朋友谈谈我炒股这些年见过的坑、亏过的钱，以及总结的一些“新手必知”。赚钱的方式很多，每个投资人最终都会形成自己的交易体系，前提是要活下来，而亏钱的原因大致雷同。 查理芒格说：“如果你知道会死在什么地方，就不要去那个地方。” PS：这篇文章仅限给初入坑的朋友扫盲，美股老司机已经形成自己的交易体系就不用看啦！ 1，毛票/低价股 不要碰！永远都不要碰！ 珍惜生命，远离毛票！ 太多人说过了！但是我仍然觉得可以作为第一个重点。 毛票指股价不足1美元的股票，（实际我泛指低价股），这些股票是绝对的妖股，每天上下波动百分之几十常有，不是说大家都赚不到这个波动的钱，但是作为新手，这就是赌博、扔骰子，可能你运气好，赌对了一两次，但是千万不要有一种盲目自信以为自己运气好到能总猜对。 首先，毛票往往伴随着退市和破产的风险： 纳斯达克交易所规定，上市公司每股价格不足$1，且这种状态持续30个交易日，纳斯达克将发出警告，被警告的公司如果在警告发出的90天内，仍然不能采取相应的措施进行自救（比如说合股），将被停止交易，转到粉单市场交易。 有很多低价股公司通常面临债务或者业务上各种各样的问题，这样的公司极有可能破产。公司破产会有两种情况：1、直接破产，普通股变成废纸；2、申请破产保护，股票进入粉单。这个 @vision 写过一","listText":"最近社区有个话题#为啥你亏钱#看的朋友很多，反思过去才能展望未来。 这篇标题借罗振宇老师的《时间的朋友》，我觉得投资是真正的要跟时间做朋友，这条路上的风景很美，有刺激、有平淡、有孤独、有浮躁， 但！首先你要活得够长。 进入2017年，我炒股也小十年了，美股第六年。运气很好，经历过闭着眼睛都赚钱的年份。但也亲眼看着$Facebook(FB)$从38刀上市破发、到腰斩再从18刀一路走到现在；见识过昔日明星股GTAT一夜暴跌90%+；全程跟踪了奇虎等中概股从上市到退市。 今天想跟初入美股的朋友谈谈我炒股这些年见过的坑、亏过的钱，以及总结的一些“新手必知”。赚钱的方式很多，每个投资人最终都会形成自己的交易体系，前提是要活下来，而亏钱的原因大致雷同。 查理芒格说：“如果你知道会死在什么地方，就不要去那个地方。” PS：这篇文章仅限给初入坑的朋友扫盲，美股老司机已经形成自己的交易体系就不用看啦！ 1，毛票/低价股 不要碰！永远都不要碰！ 珍惜生命，远离毛票！ 太多人说过了！但是我仍然觉得可以作为第一个重点。 毛票指股价不足1美元的股票，（实际我泛指低价股），这些股票是绝对的妖股，每天上下波动百分之几十常有，不是说大家都赚不到这个波动的钱，但是作为新手，这就是赌博、扔骰子，可能你运气好，赌对了一两次，但是千万不要有一种盲目自信以为自己运气好到能总猜对。 首先，毛票往往伴随着退市和破产的风险： 纳斯达克交易所规定，上市公司每股价格不足$1，且这种状态持续30个交易日，纳斯达克将发出警告，被警告的公司如果在警告发出的90天内，仍然不能采取相应的措施进行自救（比如说合股），将被停止交易，转到粉单市场交易。 有很多低价股公司通常面临债务或者业务上各种各样的问题，这样的公司极有可能破产。公司破产会有两种情况：1、直接破产，普通股变成废纸；2、申请破产保护，股票进入粉单。这个 @vision 写过一","text":"最近社区有个话题#为啥你亏钱#看的朋友很多，反思过去才能展望未来。 这篇标题借罗振宇老师的《时间的朋友》，我觉得投资是真正的要跟时间做朋友，这条路上的风景很美，有刺激、有平淡、有孤独、有浮躁， 但！首先你要活得够长。 进入2017年，我炒股也小十年了，美股第六年。运气很好，经历过闭着眼睛都赚钱的年份。但也亲眼看着$Facebook(FB)$从38刀上市破发、到腰斩再从18刀一路走到现在；见识过昔日明星股GTAT一夜暴跌90%+；全程跟踪了奇虎等中概股从上市到退市。 今天想跟初入美股的朋友谈谈我炒股这些年见过的坑、亏过的钱，以及总结的一些“新手必知”。赚钱的方式很多，每个投资人最终都会形成自己的交易体系，前提是要活下来，而亏钱的原因大致雷同。 查理芒格说：“如果你知道会死在什么地方，就不要去那个地方。” PS：这篇文章仅限给初入坑的朋友扫盲，美股老司机已经形成自己的交易体系就不用看啦！ 1，毛票/低价股 不要碰！永远都不要碰！ 珍惜生命，远离毛票！ 太多人说过了！但是我仍然觉得可以作为第一个重点。 毛票指股价不足1美元的股票，（实际我泛指低价股），这些股票是绝对的妖股，每天上下波动百分之几十常有，不是说大家都赚不到这个波动的钱，但是作为新手，这就是赌博、扔骰子，可能你运气好，赌对了一两次，但是千万不要有一种盲目自信以为自己运气好到能总猜对。 首先，毛票往往伴随着退市和破产的风险： 纳斯达克交易所规定，上市公司每股价格不足$1，且这种状态持续30个交易日，纳斯达克将发出警告，被警告的公司如果在警告发出的90天内，仍然不能采取相应的措施进行自救（比如说合股），将被停止交易，转到粉单市场交易。 有很多低价股公司通常面临债务或者业务上各种各样的问题，这样的公司极有可能破产。公司破产会有两种情况：1、直接破产，普通股变成废纸；2、申请破产保护，股票进入粉单。这个 @vision 写过一","images":[{"img":"https://static.laohu8.com/54b045019b8c647bf64d48fa44214993"},{"img":"https://static.laohu8.com/2a3d8b4eb16d708b2a8cb9d985e9f7d8"},{"img":"https://static.laohu8.com/53a1653652fbd64de5337d7fb2ff13bc"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/45492","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2687,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":626535554,"gmtCreate":1674465072078,"gmtModify":1674465075721,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"看了一下前面交易记录，为啥kala买时1160股，卖时候总共只有46股（全部清仓kala），太坑了吧？谁帮我解答一下","listText":"看了一下前面交易记录，为啥kala买时1160股，卖时候总共只有46股（全部清仓kala），太坑了吧？谁帮我解答一下","text":"看了一下前面交易记录，为啥kala买时1160股，卖时候总共只有46股（全部清仓kala），太坑了吧？谁帮我解答一下","images":[{"img":"https://static.tigerbbs.com/32b8ec3071f74782507afffb8a484a72","width":"1080","height":"2340"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":6,"repostSize":1,"link":"https://laohu8.com/post/626535554","isVote":1,"tweetType":1,"viewCount":3806,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":617715220,"gmtCreate":1654612915062,"gmtModify":1704859891252,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>下单为啥产生借款，啥意思","listText":"<a href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>下单为啥产生借款，啥意思","text":"$奥罗拉大麻公司(ACB)$下单为啥产生借款，啥意思","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/617715220","isVote":1,"tweetType":1,"viewCount":5003,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":635499516,"gmtCreate":1647177006369,"gmtModify":1647177006369,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"会爆发吗？","listText":"会爆发吗？","text":"会爆发吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/635499516","repostId":"2219404832","repostType":2,"repost":{"id":"2219404832","kind":"highlight","pubTimestamp":1647144990,"share":"https://www.laohu8.com/m/news/2219404832?lang=&edition=full","pubTime":"2022-03-13 12:16","market":"us","language":"zh","title":"辉瑞Paxlovid药片下周获准仿制，最快将于12月前供应","url":"https://stock-news.laohu8.com/highlight/detail?id=2219404832","media":"华尔街见闻","summary":"在与辉瑞达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和","content":"<html><head></head><body><p>在与<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和监管方面的障碍，世界部分地区可能要等待一年的时间才能获得该药物。</p><p><b>MPP称，制药商可能准备在今年12月前提供第一批Paxlovid药片。分析公司Airfinity估计，更大的数量可能要到2023年5月才能进入市场。</b></p><p>去年11月辉瑞宣布，其新冠口服药Paxlovid在临床试验中将轻度和中度患者住院或死亡概率降低89%，由于高疗效，预计对这种药物的需求将超过供应。</p><p>目前为止，一些较富裕的国家已经获得了辉瑞Paxlovid约四分之一的初始供应。这给辉瑞和其他公司带来了越来越大的压力，要求他们加快在难以获得疫苗的低收入国家推出Paxlovid。</p><p>而今年1月，已有27家药企获准仿制<a href=\"https://laohu8.com/S/MRK\">默沙东</a>新冠口服药——MPP宣布与它们达成协议，将为全球105个国家或地区生产及供应高质量、可负担的默沙东口服抗新冠病毒药物Molnupiravir仿制药，<b>其中五家中国药企入围。</b></p><p>辉瑞公司发言人Kit Longley表示，辉瑞正在“集中努力和资源，以最大限度提高总体供应”。Longley在一封电子邮件中说，该公司已与包括低收入国家在内的 100 多个国家进行了接洽，并正在与世卫组织合作，分享有关其治疗、定价和供应方面的信息。</p><p>Paxlovid 由两片药片组成。其中一片是尼马瑞韦片（nirmatrelvir），是一种新药，旨在抑制SARS-CoV-2蛋白，以阻止病毒复制；另一片是利托那韦(ritonavir)，可减缓尼马瑞韦的分解，以帮助其在较高浓度下在体内保持更长时间的活性。</p><h2>制药商生产辉瑞药物预计会更加困难</h2><p>与默沙东的molnupiravir相比，辉瑞Paxlovid似乎是一种更有效的抗病毒药物。</p><p>默沙东去年底公布，其新冠特效药molnupiravir后期试验显示，能将死亡和住院机率降低一半。不过，随后分析显示，此药疗效只有30%，低于预期。在美国和英国，默沙东的新冠特效药molnupiravir都处于“替补”的位置。医疗人员纷纷表示除非其他新冠药物失败或者被认为不适合病人，才会考虑molnupiravir。</p><p>但与默沙东特效药相比，制药商生产自己的辉瑞药物预计会更加困难。</p><p>根据MPP，<b>关于辉瑞联合疗法中的新药nirmatrelvir的公开信息相对有限，制造商不得不等待许可及获得辉瑞的原始产品。</b></p><p>MPP执行董事查尔斯·戈尔(Charles Gore)表示，有一些不可避免的障碍和复杂性需要时间来解决，包括监管机构的批准，以及证明辉瑞这种药物可以随着时间的推移保持其特性。</p><p>据彭博，英国利物浦大学高级研究员安德鲁·希尔(Andrew Hill)表示，<b>制造Paxlovid的另一个潜在挑战是获取原材料。据Airfinity数据，该药生产过程需要从全球供应商大量采购38种不同的原料和试剂。</b>虽然目前还没有任何已知的短缺，但未来可能会存在瓶颈。</p><p>希尔补充说，尽管辉瑞承诺扩大其药物的可获得性，<b>但鉴于新冠疫情发展轨迹的不确定性，一些制造商也不确定需求和能否收回成本。</b></p><p>辉瑞已经采取措施扩大其药物的可获得性。除了签署许可协议，并承诺不会从低收入国家的销售中收取特许权使用费外，该公司还表示，在疫情期间，它将采用分层定价体系，富裕国家支付更多费用。据非洲官员说，该公司还达成了向非洲供货的初步协议。</p><p><b>辉瑞已经将2022年Paxlovid的产量预计提高到1.2亿疗程，并计划今年在美国交付2000万疗程。</b>Airfinity数据显示，英国购买了约275万疗程，另外1000万疗程将用于低收入国家。</p><p>尽管如此，健康倡导者仍呼吁该公司向发展中国家分配更多疗程，并将Paxlovid提供给评估其与其他新冠特效药联合使用的研究人员。他们说，许多国家的新冠病毒检测能力可能不够，这也可能带来一个问题，因为Paxlovid需在症状开始后不超过5天内服用。</p></body></html>","source":"wallstreetcn_api","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>辉瑞Paxlovid药片下周获准仿制，最快将于12月前供应</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n辉瑞Paxlovid药片下周获准仿制，最快将于12月前供应\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-13 12:16 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3654085><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>在与辉瑞达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和监管方面的障碍，世界部分地区可能要等待一年的时间才能获得该药物。MPP称，制药商可能准备在今年12月前提供第一批Paxlovid药片。分析公司Airfinity估计，更大的数量可能要到2023年5月...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3654085\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f2bb9162f10407908b68d91c8d440880","relate_stocks":{},"source_url":"https://wallstreetcn.com/articles/3654085","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2219404832","content_text":"在与辉瑞达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和监管方面的障碍，世界部分地区可能要等待一年的时间才能获得该药物。MPP称，制药商可能准备在今年12月前提供第一批Paxlovid药片。分析公司Airfinity估计，更大的数量可能要到2023年5月才能进入市场。去年11月辉瑞宣布，其新冠口服药Paxlovid在临床试验中将轻度和中度患者住院或死亡概率降低89%，由于高疗效，预计对这种药物的需求将超过供应。目前为止，一些较富裕的国家已经获得了辉瑞Paxlovid约四分之一的初始供应。这给辉瑞和其他公司带来了越来越大的压力，要求他们加快在难以获得疫苗的低收入国家推出Paxlovid。而今年1月，已有27家药企获准仿制默沙东新冠口服药——MPP宣布与它们达成协议，将为全球105个国家或地区生产及供应高质量、可负担的默沙东口服抗新冠病毒药物Molnupiravir仿制药，其中五家中国药企入围。辉瑞公司发言人Kit Longley表示，辉瑞正在“集中努力和资源，以最大限度提高总体供应”。Longley在一封电子邮件中说，该公司已与包括低收入国家在内的 100 多个国家进行了接洽，并正在与世卫组织合作，分享有关其治疗、定价和供应方面的信息。Paxlovid 由两片药片组成。其中一片是尼马瑞韦片（nirmatrelvir），是一种新药，旨在抑制SARS-CoV-2蛋白，以阻止病毒复制；另一片是利托那韦(ritonavir)，可减缓尼马瑞韦的分解，以帮助其在较高浓度下在体内保持更长时间的活性。制药商生产辉瑞药物预计会更加困难与默沙东的molnupiravir相比，辉瑞Paxlovid似乎是一种更有效的抗病毒药物。默沙东去年底公布，其新冠特效药molnupiravir后期试验显示，能将死亡和住院机率降低一半。不过，随后分析显示，此药疗效只有30%，低于预期。在美国和英国，默沙东的新冠特效药molnupiravir都处于“替补”的位置。医疗人员纷纷表示除非其他新冠药物失败或者被认为不适合病人，才会考虑molnupiravir。但与默沙东特效药相比，制药商生产自己的辉瑞药物预计会更加困难。根据MPP，关于辉瑞联合疗法中的新药nirmatrelvir的公开信息相对有限，制造商不得不等待许可及获得辉瑞的原始产品。MPP执行董事查尔斯·戈尔(Charles Gore)表示，有一些不可避免的障碍和复杂性需要时间来解决，包括监管机构的批准，以及证明辉瑞这种药物可以随着时间的推移保持其特性。据彭博，英国利物浦大学高级研究员安德鲁·希尔(Andrew Hill)表示，制造Paxlovid的另一个潜在挑战是获取原材料。据Airfinity数据，该药生产过程需要从全球供应商大量采购38种不同的原料和试剂。虽然目前还没有任何已知的短缺，但未来可能会存在瓶颈。希尔补充说，尽管辉瑞承诺扩大其药物的可获得性，但鉴于新冠疫情发展轨迹的不确定性，一些制造商也不确定需求和能否收回成本。辉瑞已经采取措施扩大其药物的可获得性。除了签署许可协议，并承诺不会从低收入国家的销售中收取特许权使用费外，该公司还表示，在疫情期间，它将采用分层定价体系，富裕国家支付更多费用。据非洲官员说，该公司还达成了向非洲供货的初步协议。辉瑞已经将2022年Paxlovid的产量预计提高到1.2亿疗程，并计划今年在美国交付2000万疗程。Airfinity数据显示，英国购买了约275万疗程，另外1000万疗程将用于低收入国家。尽管如此，健康倡导者仍呼吁该公司向发展中国家分配更多疗程，并将Paxlovid提供给评估其与其他新冠特效药联合使用的研究人员。他们说，许多国家的新冠病毒检测能力可能不够，这也可能带来一个问题，因为Paxlovid需在症状开始后不超过5天内服用。","news_type":1},"isVote":1,"tweetType":1,"viewCount":3001,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":631825332,"gmtCreate":1644589952158,"gmtModify":1644589952158,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a>每次都是盘前跌","listText":"<a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a>每次都是盘前跌","text":"$辉瑞(PFE)$每次都是盘前跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/631825332","isVote":1,"tweetType":1,"viewCount":3361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633716086,"gmtCreate":1644321883227,"gmtModify":1644321883227,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"预估，有用吗？按实际出发呀，瞎搞","listText":"预估，有用吗？按实际出发呀，瞎搞","text":"预估，有用吗？按实际出发呀，瞎搞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633716086","repostId":"2209583128","repostType":2,"isVote":1,"tweetType":1,"viewCount":2180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639945278,"gmtCreate":1643146880531,"gmtModify":1643147809529,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>搞鸡儿，财报利好还跌得厉害","listText":"<a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>搞鸡儿，财报利好还跌得厉害","text":"$微软(MSFT)$搞鸡儿，财报利好还跌得厉害","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639945278","isVote":1,"tweetType":1,"viewCount":1656,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630847661,"gmtCreate":1642782063194,"gmtModify":1642782063194,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"利好，为啥跌跌不休","listText":"利好，为啥跌跌不休","text":"利好，为啥跌跌不休","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630847661","repostId":"2205504738","repostType":2,"isVote":1,"tweetType":1,"viewCount":1626,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":348454,"gmtCreate":1544111514725,"gmtModify":1704783050128,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"$惠普企业(HPE)$啥情况，难道和华为有关","listText":"$惠普企业(HPE)$啥情况，难道和华为有关","text":"$惠普企业(HPE)$啥情况，难道和华为有关","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/348454","isVote":1,"tweetType":1,"viewCount":3811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":322312,"gmtCreate":1541168393119,"gmtModify":1704779684805,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3463959459277747","authorIdStr":"3463959459277747"},"themes":[],"htmlText":"$红帽(RHT)$天天双杀","listText":"$红帽(RHT)$天天双杀","text":"$红帽(RHT)$天天双杀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/322312","isVote":1,"tweetType":1,"viewCount":1670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":626535554,"gmtCreate":1674465072078,"gmtModify":1674465075721,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"看了一下前面交易记录，为啥kala买时1160股，卖时候总共只有46股（全部清仓kala），太坑了吧？谁帮我解答一下","listText":"看了一下前面交易记录，为啥kala买时1160股，卖时候总共只有46股（全部清仓kala），太坑了吧？谁帮我解答一下","text":"看了一下前面交易记录，为啥kala买时1160股，卖时候总共只有46股（全部清仓kala），太坑了吧？谁帮我解答一下","images":[{"img":"https://static.tigerbbs.com/32b8ec3071f74782507afffb8a484a72","width":"1080","height":"2340"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":6,"repostSize":1,"link":"https://laohu8.com/post/626535554","isVote":1,"tweetType":1,"viewCount":3806,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":276504536363232,"gmtCreate":1708534375415,"gmtModify":1708534455300,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$ &nbsp;</a>天天跌，垃圾股","listText":"<a href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$ &nbsp;</a>天天跌，垃圾股","text":"$Roku Inc(ROKU)$ 天天跌，垃圾股","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/276504536363232","isVote":1,"tweetType":1,"viewCount":3837,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":617715220,"gmtCreate":1654612915062,"gmtModify":1704859891252,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>下单为啥产生借款，啥意思","listText":"<a href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>下单为啥产生借款，啥意思","text":"$奥罗拉大麻公司(ACB)$下单为啥产生借款，啥意思","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/617715220","isVote":1,"tweetType":1,"viewCount":5003,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639945278,"gmtCreate":1643146880531,"gmtModify":1643147809529,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>搞鸡儿，财报利好还跌得厉害","listText":"<a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a>搞鸡儿，财报利好还跌得厉害","text":"$微软(MSFT)$搞鸡儿，财报利好还跌得厉害","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639945278","isVote":1,"tweetType":1,"viewCount":1656,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":348454,"gmtCreate":1544111514725,"gmtModify":1704783050128,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"$惠普企业(HPE)$啥情况，难道和华为有关","listText":"$惠普企业(HPE)$啥情况，难道和华为有关","text":"$惠普企业(HPE)$啥情况，难道和华为有关","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/348454","isVote":1,"tweetType":1,"viewCount":3811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":321189833932888,"gmtCreate":1719445731405,"gmtModify":1719449461483,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"什么情况，业绩好还下跌，业绩不好也下跌，全贫一张嘴，什么指引，扯淡","listText":"什么情况，业绩好还下跌，业绩不好也下跌，全贫一张嘴，什么指引，扯淡","text":"什么情况，业绩好还下跌，业绩不好也下跌，全贫一张嘴，什么指引，扯淡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321189833932888","repostId":"2446441923","repostType":2,"isVote":1,"tweetType":1,"viewCount":2218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":275919158886408,"gmtCreate":1708402125035,"gmtModify":1708402126497,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/275919158886408","repostId":"1142974079","repostType":4,"isVote":1,"tweetType":1,"viewCount":2495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":274329617059880,"gmtCreate":1708012769262,"gmtModify":1708013448631,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"垃圾吧，不罚他","listText":"垃圾吧，不罚他","text":"垃圾吧，不罚他","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/274329617059880","repostId":"2411599588","repostType":2,"repost":{"id":"2411599588","kind":"news","pubTimestamp":1707982306,"share":"https://www.laohu8.com/m/news/2411599588?lang=&edition=full","pubTime":"2024-02-15 15:31","market":"hk","language":"zh","title":"网约车公司 Lyft 财报多写一个 0，股价经历过山车飙升后又回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2411599588","media":"IT之家","summary":"IT之家 2 月 15 日消息，美国网约车公司 Lyft 于本周发布 2023 年财报，由于一个拼写错误多打了一个 0，导致股价一度飙升近 70%。财报最初显示 Lyft 的 2024 年利润率将提高 500 个基点，即 5%，远远超出投资者预期，因此股价一路飙升。Lyft 首席财务官 Erin Brewer 随后在公司电话会议上纠正，公司预期 2024 年利润率涨...","content":"<div>\n<p>IT之家 2 月 15 日消息，美国网约车公司 Lyft 于本周发布 2023 年财报，由于一个拼写错误多打了一个 0，导致股价一度飙升近 70%。\n财报最初显示 Lyft 的 2024 年利润率将提高 500 个基点，即 5%，远远超出投资者预期，因此股价一路飙升。Lyft 首席财务官 Erin Brewer 随后在公司电话会议上纠正，公司预期 2024 年利润率涨幅实际是 50 个基点，即 ...</p>\n\n<a href=\"https://new.qq.com/rain/a/20240215A03VQF00\">Web Link</a>\n\n</div>\n","source":"tencent_tech","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>网约车公司 Lyft 财报多写一个 0，股价经历过山车飙升后又回落</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n网约车公司 Lyft 财报多写一个 0，股价经历过山车飙升后又回落\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-15 15:31 北京时间&nbsp;&nbsp;&nbsp;<a href=https://new.qq.com/rain/a/20240215A03VQF00><strong>IT之家</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>IT之家 2 月 15 日消息，美国网约车公司 Lyft 于本周发布 2023 年财报，由于一个拼写错误多打了一个 0，导致股价一度飙升近 70%。\n财报最初显示 Lyft 的 2024 年利润率将提高 500 个基点，即 5%，远远超出投资者预期，因此股价一路飙升。Lyft 首席财务官 Erin Brewer 随后在公司电话会议上纠正，公司预期 2024 年利润率涨幅实际是 50 个基点，即 ...</p>\n\n<a href=\"https://new.qq.com/rain/a/20240215A03VQF00\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://inews.gtimg.com/om_ls/OpE6udMuIy1Ahz2uT4kv2xvY0j7wpSc97Oh4-JLUkrj3cAA_294195/0","relate_stocks":{"LYFT":"Lyft, Inc."},"source_url":"https://new.qq.com/rain/a/20240215A03VQF00","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2411599588","content_text":"IT之家 2 月 15 日消息，美国网约车公司 Lyft 于本周发布 2023 年财报，由于一个拼写错误多打了一个 0，导致股价一度飙升近 70%。\n财报最初显示 Lyft 的 2024 年利润率将提高 500 个基点，即 5%，远远超出投资者预期，因此股价一路飙升。Lyft 首席财务官 Erin Brewer 随后在公司电话会议上纠正，公司预期 2024 年利润率涨幅实际是 50 个基点，即 0.5%。\n\n\n\n截至IT之家发文，Lyft 的股价依然有着 35% 左右的稳定涨幅，原因是 Lyft 更正后的财报依然超出预期。\n报告显示，Lyft 2023 年第四季度营收为 12.25 亿美元（IT之家备注：当前约 88.32 亿元人民币），与上年同期的 11.75 亿美元相比增长 4%，与上一季度的 11.58 亿美元相比也有所增长；净亏损为 2630 万美元（当前约 1.9 亿元人民币），与上年同期的净亏损 5.881 亿美元相比大幅收窄；不计入某些一次性项目（不按照美国通用会计准则），Lyft 第四季度调整后净利润为 7110 万美元（当前约 5.13 亿元人民币），而上年同期的调整后净亏损为 2.708 亿美元，同比扭亏为盈。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2491,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":249531986985192,"gmtCreate":1701960978550,"gmtModify":1701960981372,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"万能的社区，有人知道现在公司股票英文咨询用啥翻译软件","listText":"万能的社区，有人知道现在公司股票英文咨询用啥翻译软件","text":"万能的社区，有人知道现在公司股票英文咨询用啥翻译软件","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/249531986985192","isVote":1,"tweetType":1,"viewCount":3107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":223707017080896,"gmtCreate":1695653128227,"gmtModify":1695653129618,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"不错","listText":"不错","text":"不错","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/223707017080896","repostId":"45492","repostType":1,"repost":{"id":45492,"gmtCreate":1487756403694,"gmtModify":1704875193978,"author":{"id":"740450932848","authorId":"740450932848","name":"33_Tiger","avatar":"https://static.tigerbbs.com/aa2c2a58a713dadbb19ede7c4c37d61d","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"740450932848","idStr":"740450932848"},"themes":[],"title":"做时间的朋友 - 写给每个美股新朋友","htmlText":"最近社区有个话题#为啥你亏钱#看的朋友很多，反思过去才能展望未来。 这篇标题借罗振宇老师的《时间的朋友》，我觉得投资是真正的要跟时间做朋友，这条路上的风景很美，有刺激、有平淡、有孤独、有浮躁， 但！首先你要活得够长。 进入2017年，我炒股也小十年了，美股第六年。运气很好，经历过闭着眼睛都赚钱的年份。但也亲眼看着$Facebook(FB)$从38刀上市破发、到腰斩再从18刀一路走到现在；见识过昔日明星股GTAT一夜暴跌90%+；全程跟踪了奇虎等中概股从上市到退市。 今天想跟初入美股的朋友谈谈我炒股这些年见过的坑、亏过的钱，以及总结的一些“新手必知”。赚钱的方式很多，每个投资人最终都会形成自己的交易体系，前提是要活下来，而亏钱的原因大致雷同。 查理芒格说：“如果你知道会死在什么地方，就不要去那个地方。” PS：这篇文章仅限给初入坑的朋友扫盲，美股老司机已经形成自己的交易体系就不用看啦！ 1，毛票/低价股 不要碰！永远都不要碰！ 珍惜生命，远离毛票！ 太多人说过了！但是我仍然觉得可以作为第一个重点。 毛票指股价不足1美元的股票，（实际我泛指低价股），这些股票是绝对的妖股，每天上下波动百分之几十常有，不是说大家都赚不到这个波动的钱，但是作为新手，这就是赌博、扔骰子，可能你运气好，赌对了一两次，但是千万不要有一种盲目自信以为自己运气好到能总猜对。 首先，毛票往往伴随着退市和破产的风险： 纳斯达克交易所规定，上市公司每股价格不足$1，且这种状态持续30个交易日，纳斯达克将发出警告，被警告的公司如果在警告发出的90天内，仍然不能采取相应的措施进行自救（比如说合股），将被停止交易，转到粉单市场交易。 有很多低价股公司通常面临债务或者业务上各种各样的问题，这样的公司极有可能破产。公司破产会有两种情况：1、直接破产，普通股变成废纸；2、申请破产保护，股票进入粉单。这个 @vision 写过一","listText":"最近社区有个话题#为啥你亏钱#看的朋友很多，反思过去才能展望未来。 这篇标题借罗振宇老师的《时间的朋友》，我觉得投资是真正的要跟时间做朋友，这条路上的风景很美，有刺激、有平淡、有孤独、有浮躁， 但！首先你要活得够长。 进入2017年，我炒股也小十年了，美股第六年。运气很好，经历过闭着眼睛都赚钱的年份。但也亲眼看着$Facebook(FB)$从38刀上市破发、到腰斩再从18刀一路走到现在；见识过昔日明星股GTAT一夜暴跌90%+；全程跟踪了奇虎等中概股从上市到退市。 今天想跟初入美股的朋友谈谈我炒股这些年见过的坑、亏过的钱，以及总结的一些“新手必知”。赚钱的方式很多，每个投资人最终都会形成自己的交易体系，前提是要活下来，而亏钱的原因大致雷同。 查理芒格说：“如果你知道会死在什么地方，就不要去那个地方。” PS：这篇文章仅限给初入坑的朋友扫盲，美股老司机已经形成自己的交易体系就不用看啦！ 1，毛票/低价股 不要碰！永远都不要碰！ 珍惜生命，远离毛票！ 太多人说过了！但是我仍然觉得可以作为第一个重点。 毛票指股价不足1美元的股票，（实际我泛指低价股），这些股票是绝对的妖股，每天上下波动百分之几十常有，不是说大家都赚不到这个波动的钱，但是作为新手，这就是赌博、扔骰子，可能你运气好，赌对了一两次，但是千万不要有一种盲目自信以为自己运气好到能总猜对。 首先，毛票往往伴随着退市和破产的风险： 纳斯达克交易所规定，上市公司每股价格不足$1，且这种状态持续30个交易日，纳斯达克将发出警告，被警告的公司如果在警告发出的90天内，仍然不能采取相应的措施进行自救（比如说合股），将被停止交易，转到粉单市场交易。 有很多低价股公司通常面临债务或者业务上各种各样的问题，这样的公司极有可能破产。公司破产会有两种情况：1、直接破产，普通股变成废纸；2、申请破产保护，股票进入粉单。这个 @vision 写过一","text":"最近社区有个话题#为啥你亏钱#看的朋友很多，反思过去才能展望未来。 这篇标题借罗振宇老师的《时间的朋友》，我觉得投资是真正的要跟时间做朋友，这条路上的风景很美，有刺激、有平淡、有孤独、有浮躁， 但！首先你要活得够长。 进入2017年，我炒股也小十年了，美股第六年。运气很好，经历过闭着眼睛都赚钱的年份。但也亲眼看着$Facebook(FB)$从38刀上市破发、到腰斩再从18刀一路走到现在；见识过昔日明星股GTAT一夜暴跌90%+；全程跟踪了奇虎等中概股从上市到退市。 今天想跟初入美股的朋友谈谈我炒股这些年见过的坑、亏过的钱，以及总结的一些“新手必知”。赚钱的方式很多，每个投资人最终都会形成自己的交易体系，前提是要活下来，而亏钱的原因大致雷同。 查理芒格说：“如果你知道会死在什么地方，就不要去那个地方。” PS：这篇文章仅限给初入坑的朋友扫盲，美股老司机已经形成自己的交易体系就不用看啦！ 1，毛票/低价股 不要碰！永远都不要碰！ 珍惜生命，远离毛票！ 太多人说过了！但是我仍然觉得可以作为第一个重点。 毛票指股价不足1美元的股票，（实际我泛指低价股），这些股票是绝对的妖股，每天上下波动百分之几十常有，不是说大家都赚不到这个波动的钱，但是作为新手，这就是赌博、扔骰子，可能你运气好，赌对了一两次，但是千万不要有一种盲目自信以为自己运气好到能总猜对。 首先，毛票往往伴随着退市和破产的风险： 纳斯达克交易所规定，上市公司每股价格不足$1，且这种状态持续30个交易日，纳斯达克将发出警告，被警告的公司如果在警告发出的90天内，仍然不能采取相应的措施进行自救（比如说合股），将被停止交易，转到粉单市场交易。 有很多低价股公司通常面临债务或者业务上各种各样的问题，这样的公司极有可能破产。公司破产会有两种情况：1、直接破产，普通股变成废纸；2、申请破产保护，股票进入粉单。这个 @vision 写过一","images":[{"img":"https://static.laohu8.com/54b045019b8c647bf64d48fa44214993"},{"img":"https://static.laohu8.com/2a3d8b4eb16d708b2a8cb9d985e9f7d8"},{"img":"https://static.laohu8.com/53a1653652fbd64de5337d7fb2ff13bc"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/45492","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2687,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":635499516,"gmtCreate":1647177006369,"gmtModify":1647177006369,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"会爆发吗？","listText":"会爆发吗？","text":"会爆发吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/635499516","repostId":"2219404832","repostType":2,"repost":{"id":"2219404832","kind":"highlight","pubTimestamp":1647144990,"share":"https://www.laohu8.com/m/news/2219404832?lang=&edition=full","pubTime":"2022-03-13 12:16","market":"us","language":"zh","title":"辉瑞Paxlovid药片下周获准仿制，最快将于12月前供应","url":"https://stock-news.laohu8.com/highlight/detail?id=2219404832","media":"华尔街见闻","summary":"在与辉瑞达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和","content":"<html><head></head><body><p>在与<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和监管方面的障碍，世界部分地区可能要等待一年的时间才能获得该药物。</p><p><b>MPP称，制药商可能准备在今年12月前提供第一批Paxlovid药片。分析公司Airfinity估计，更大的数量可能要到2023年5月才能进入市场。</b></p><p>去年11月辉瑞宣布，其新冠口服药Paxlovid在临床试验中将轻度和中度患者住院或死亡概率降低89%，由于高疗效，预计对这种药物的需求将超过供应。</p><p>目前为止，一些较富裕的国家已经获得了辉瑞Paxlovid约四分之一的初始供应。这给辉瑞和其他公司带来了越来越大的压力，要求他们加快在难以获得疫苗的低收入国家推出Paxlovid。</p><p>而今年1月，已有27家药企获准仿制<a href=\"https://laohu8.com/S/MRK\">默沙东</a>新冠口服药——MPP宣布与它们达成协议，将为全球105个国家或地区生产及供应高质量、可负担的默沙东口服抗新冠病毒药物Molnupiravir仿制药，<b>其中五家中国药企入围。</b></p><p>辉瑞公司发言人Kit Longley表示，辉瑞正在“集中努力和资源，以最大限度提高总体供应”。Longley在一封电子邮件中说，该公司已与包括低收入国家在内的 100 多个国家进行了接洽，并正在与世卫组织合作，分享有关其治疗、定价和供应方面的信息。</p><p>Paxlovid 由两片药片组成。其中一片是尼马瑞韦片（nirmatrelvir），是一种新药，旨在抑制SARS-CoV-2蛋白，以阻止病毒复制；另一片是利托那韦(ritonavir)，可减缓尼马瑞韦的分解，以帮助其在较高浓度下在体内保持更长时间的活性。</p><h2>制药商生产辉瑞药物预计会更加困难</h2><p>与默沙东的molnupiravir相比，辉瑞Paxlovid似乎是一种更有效的抗病毒药物。</p><p>默沙东去年底公布，其新冠特效药molnupiravir后期试验显示，能将死亡和住院机率降低一半。不过，随后分析显示，此药疗效只有30%，低于预期。在美国和英国，默沙东的新冠特效药molnupiravir都处于“替补”的位置。医疗人员纷纷表示除非其他新冠药物失败或者被认为不适合病人，才会考虑molnupiravir。</p><p>但与默沙东特效药相比，制药商生产自己的辉瑞药物预计会更加困难。</p><p>根据MPP，<b>关于辉瑞联合疗法中的新药nirmatrelvir的公开信息相对有限，制造商不得不等待许可及获得辉瑞的原始产品。</b></p><p>MPP执行董事查尔斯·戈尔(Charles Gore)表示，有一些不可避免的障碍和复杂性需要时间来解决，包括监管机构的批准，以及证明辉瑞这种药物可以随着时间的推移保持其特性。</p><p>据彭博，英国利物浦大学高级研究员安德鲁·希尔(Andrew Hill)表示，<b>制造Paxlovid的另一个潜在挑战是获取原材料。据Airfinity数据，该药生产过程需要从全球供应商大量采购38种不同的原料和试剂。</b>虽然目前还没有任何已知的短缺，但未来可能会存在瓶颈。</p><p>希尔补充说，尽管辉瑞承诺扩大其药物的可获得性，<b>但鉴于新冠疫情发展轨迹的不确定性，一些制造商也不确定需求和能否收回成本。</b></p><p>辉瑞已经采取措施扩大其药物的可获得性。除了签署许可协议，并承诺不会从低收入国家的销售中收取特许权使用费外，该公司还表示，在疫情期间，它将采用分层定价体系，富裕国家支付更多费用。据非洲官员说，该公司还达成了向非洲供货的初步协议。</p><p><b>辉瑞已经将2022年Paxlovid的产量预计提高到1.2亿疗程，并计划今年在美国交付2000万疗程。</b>Airfinity数据显示，英国购买了约275万疗程，另外1000万疗程将用于低收入国家。</p><p>尽管如此，健康倡导者仍呼吁该公司向发展中国家分配更多疗程，并将Paxlovid提供给评估其与其他新冠特效药联合使用的研究人员。他们说，许多国家的新冠病毒检测能力可能不够，这也可能带来一个问题，因为Paxlovid需在症状开始后不超过5天内服用。</p></body></html>","source":"wallstreetcn_api","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>辉瑞Paxlovid药片下周获准仿制，最快将于12月前供应</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n辉瑞Paxlovid药片下周获准仿制，最快将于12月前供应\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-13 12:16 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3654085><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>在与辉瑞达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和监管方面的障碍，世界部分地区可能要等待一年的时间才能获得该药物。MPP称，制药商可能准备在今年12月前提供第一批Paxlovid药片。分析公司Airfinity估计，更大的数量可能要到2023年5月...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3654085\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f2bb9162f10407908b68d91c8d440880","relate_stocks":{},"source_url":"https://wallstreetcn.com/articles/3654085","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2219404832","content_text":"在与辉瑞达成许可协议四个月后，联合国支持的药品专利池组织（Medicines PatentPool, MPP）计划于下周公布将要生产辉瑞新冠口服特效药paxlovid的仿制药制造商名单，不过由于生产和监管方面的障碍，世界部分地区可能要等待一年的时间才能获得该药物。MPP称，制药商可能准备在今年12月前提供第一批Paxlovid药片。分析公司Airfinity估计，更大的数量可能要到2023年5月才能进入市场。去年11月辉瑞宣布，其新冠口服药Paxlovid在临床试验中将轻度和中度患者住院或死亡概率降低89%，由于高疗效，预计对这种药物的需求将超过供应。目前为止，一些较富裕的国家已经获得了辉瑞Paxlovid约四分之一的初始供应。这给辉瑞和其他公司带来了越来越大的压力，要求他们加快在难以获得疫苗的低收入国家推出Paxlovid。而今年1月，已有27家药企获准仿制默沙东新冠口服药——MPP宣布与它们达成协议，将为全球105个国家或地区生产及供应高质量、可负担的默沙东口服抗新冠病毒药物Molnupiravir仿制药，其中五家中国药企入围。辉瑞公司发言人Kit Longley表示，辉瑞正在“集中努力和资源，以最大限度提高总体供应”。Longley在一封电子邮件中说，该公司已与包括低收入国家在内的 100 多个国家进行了接洽，并正在与世卫组织合作，分享有关其治疗、定价和供应方面的信息。Paxlovid 由两片药片组成。其中一片是尼马瑞韦片（nirmatrelvir），是一种新药，旨在抑制SARS-CoV-2蛋白，以阻止病毒复制；另一片是利托那韦(ritonavir)，可减缓尼马瑞韦的分解，以帮助其在较高浓度下在体内保持更长时间的活性。制药商生产辉瑞药物预计会更加困难与默沙东的molnupiravir相比，辉瑞Paxlovid似乎是一种更有效的抗病毒药物。默沙东去年底公布，其新冠特效药molnupiravir后期试验显示，能将死亡和住院机率降低一半。不过，随后分析显示，此药疗效只有30%，低于预期。在美国和英国，默沙东的新冠特效药molnupiravir都处于“替补”的位置。医疗人员纷纷表示除非其他新冠药物失败或者被认为不适合病人，才会考虑molnupiravir。但与默沙东特效药相比，制药商生产自己的辉瑞药物预计会更加困难。根据MPP，关于辉瑞联合疗法中的新药nirmatrelvir的公开信息相对有限，制造商不得不等待许可及获得辉瑞的原始产品。MPP执行董事查尔斯·戈尔(Charles Gore)表示，有一些不可避免的障碍和复杂性需要时间来解决，包括监管机构的批准，以及证明辉瑞这种药物可以随着时间的推移保持其特性。据彭博，英国利物浦大学高级研究员安德鲁·希尔(Andrew Hill)表示，制造Paxlovid的另一个潜在挑战是获取原材料。据Airfinity数据，该药生产过程需要从全球供应商大量采购38种不同的原料和试剂。虽然目前还没有任何已知的短缺，但未来可能会存在瓶颈。希尔补充说，尽管辉瑞承诺扩大其药物的可获得性，但鉴于新冠疫情发展轨迹的不确定性，一些制造商也不确定需求和能否收回成本。辉瑞已经采取措施扩大其药物的可获得性。除了签署许可协议，并承诺不会从低收入国家的销售中收取特许权使用费外，该公司还表示，在疫情期间，它将采用分层定价体系，富裕国家支付更多费用。据非洲官员说，该公司还达成了向非洲供货的初步协议。辉瑞已经将2022年Paxlovid的产量预计提高到1.2亿疗程，并计划今年在美国交付2000万疗程。Airfinity数据显示，英国购买了约275万疗程，另外1000万疗程将用于低收入国家。尽管如此，健康倡导者仍呼吁该公司向发展中国家分配更多疗程，并将Paxlovid提供给评估其与其他新冠特效药联合使用的研究人员。他们说，许多国家的新冠病毒检测能力可能不够，这也可能带来一个问题，因为Paxlovid需在症状开始后不超过5天内服用。","news_type":1},"isVote":1,"tweetType":1,"viewCount":3001,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":631825332,"gmtCreate":1644589952158,"gmtModify":1644589952158,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a>每次都是盘前跌","listText":"<a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a>每次都是盘前跌","text":"$辉瑞(PFE)$每次都是盘前跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/631825332","isVote":1,"tweetType":1,"viewCount":3361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633716086,"gmtCreate":1644321883227,"gmtModify":1644321883227,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"预估，有用吗？按实际出发呀，瞎搞","listText":"预估，有用吗？按实际出发呀，瞎搞","text":"预估，有用吗？按实际出发呀，瞎搞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633716086","repostId":"2209583128","repostType":2,"isVote":1,"tweetType":1,"viewCount":2180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630847661,"gmtCreate":1642782063194,"gmtModify":1642782063194,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"利好，为啥跌跌不休","listText":"利好，为啥跌跌不休","text":"利好，为啥跌跌不休","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630847661","repostId":"2205504738","repostType":2,"isVote":1,"tweetType":1,"viewCount":1626,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":322312,"gmtCreate":1541168393119,"gmtModify":1704779684805,"author":{"id":"3463959459277747","authorId":"3463959459277747","name":"止盈止损空仓守住","avatar":"https://static.tigerbbs.com/a5922f0febd7e43908f97e39f2746046","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3463959459277747","idStr":"3463959459277747"},"themes":[],"htmlText":"$红帽(RHT)$天天双杀","listText":"$红帽(RHT)$天天双杀","text":"$红帽(RHT)$天天双杀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/322312","isVote":1,"tweetType":1,"viewCount":1670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}